Interstellar Lab

Plant habitats for space and Earth

Interstellar Lab operates in the biosphere sector of the space industry, is headquartered in France, was founded in 2018, is at Seed stage.

Interstellar Lab at a glance

StatusActivechecked August 2026
SectorBiosphere
HeadquartersFrance
Founded2018
StageSeed
Websiteinterstellarlab.com

Record last updated August 2026 · how we verify · spotted something outdated? Tell us.

Timeline & funding

  1. April 2025Contract
  2. August 2024Funding
  3. September 2023Contract
  4. March 2022Funding
  5. March 2022Funding
    Seed: $5MUrania Ventures, Auxxo, 7percent Ventures, Seldor Capital, E2MC, Kima Ventures and Bpifrance
  6. January 2021Product

Backed by

Investors in Interstellar Lab who also back other space companies we track.

Mission

BioPods, controlled-environment capsules growing plants for space and Earth.

A BioPod is a sealed growth chamber about five metres long under an inflatable shell, recycling its own water and controlling irrigation, temperature, humidity, carbon dioxide and light spectrum automatically. NuCLEUS is the version built for space, several autonomous growth units combined to produce vegetables, mushrooms and insects on as little water and air as possible. Eden 1.0, the flight unit built for Vast's Haven-1 station, is a greenhouse capsule designed to run plant experiments with almost no crew time.

Barbara Belvisi founded the company to build closed-loop habitats for Mars and then found a way to pay for it on Earth. Growing aromatic and cosmetic botanicals under precisely repeatable conditions turns out to be worth real money to fragrance and beauty companies, because molecular consistency is what they are buying, and L'Oreal, Robertet and DSM are named customers. That is unusual here. Most companies in this directory are funded by investors and agencies; this one sells a product to people who are not in the space business.

The space half is eight years of promises with nothing flown. Eden 1.0 depends entirely on Vast, whose station has slipped by roughly eighteen months, so Interstellar Lab's first flight is now years later than the schedule it was announced against and not in the company's hands. The terrestrial business is real but small, around $1.3 million of cumulative revenue against something over $20 million raised. And the claim that one business de-risks the other deserves scrutiny: a BioPod on a farm in Provence shares a control system and a philosophy with a sealed orbital phytotron, but almost none of the constraints, not the mass budget, the crew-time budget, fluid handling without gravity, off-gassing, materials compatibility or fire safety. Closed-loop life support is a problem NASA and ESA have worked at for forty years without solving at operational scale.

Team

  • Barbara Belvisi · Founder & CEO

Follow startups like Interstellar Lab

Founder interviews and the most promising space startups, straight to your inbox. Free, no spam, unsubscribe anytime.